We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report to 30 June 2020

12 Aug 2020 10:15

RNS Number : 8426V
British Smaller Companies VCT2 Plc
12 August 2020
 

British Smaller Companies VCT2 plc

Unaudited Interim Results and Interim Management Report

for the six months ended 30 June 2020

 

British Smaller Companies VCT2 plc (the "Company") today announces its unaudited interim results for the six months to 30 June 2020.

HIGHLIGHTS

· Total Return at 30 June 2020 of 116.9p per share (31 December 2019: 121.7p)

· Two profitable realisations from unquoted investments in the period, generating total proceeds of £5.6 million, a gain of £1.6 million over the opening carrying value and £4.2 million over cost

· The Board is declaring a second interim dividend of 1.5p per share in respect of the year ending 31 December 2020 which, following the dividend of 2.0p per share paid on 12 May 2020, will bring total dividends paid in the current financial year to 3.5p per share.

· Total cumulative dividends paid since inception of 68.5p per share (31 December 2019: 66.5p per share)

CHAIRMAN'S STATEMENT

The events of the last six months have been significantly impacted by the Covid-19 pandemic which has seen movements restricted and changes in behaviour not just across the country but globally. Government economic interventions have been widespread and on scales not previously contemplated which at the micro level translated into initially internal and short-term planning but as revised trading patterns emerged medium- and longer-term planning coming back into focus. Against this backdrop it is encouraging that the Company's portfolio has, to date, not demanded significantly more investment in order to trade, has overall started to show signs of improving performance, with some sectors recovering faster than others, some less or not impacted and a small number until very recently still restricted in their activity.

This has in the short-term impacted valuations which is reflected in the results over the period, but the robustness of the funding at the individual investment level, combined with the overall liquidity of the Company and the general improvement in trading towards the end of the period are positives on which to build.

It is pleasing to report that, during the period under review, your Company achieved two significant divestments of its investments in Business Collaborator and RMS. These realised proceeds of £5.1 million and £0.6 million respectively, which when added to previous income and capital returns represented returns of 4.3x and 2.6x and together returned a profit over cost of £4.2 million, of which £1.6 million was recognised in the period.

Total Return has been impacted by the recent pandemic, at 31 March 2020 it fell by 6.8 pence per ordinary share, before recovering 2.0 pence per ordinary share standing at 116.9 pence per ordinary share at 30 June 2020.

Financial Results and Dividends

The £5.1 million proceeds from the sale of the Company's investment in Business Collaborator Limited represented a capital profit over cost of £3.7 million. The total return (including income) from this investment of £5.7 million was delivered over a 5.4 year holding period producing an Internal Rate of Return of 33 per cent.

The £0.6 million proceeds from the sale of the Company's investment in RMS Holdings Limited represented a capital profit over cost of £0.5 million. The total return (including income) from this investment of £1.1 million, was delivered over a 12.9 year holding period producing an Internal Rate of Return of 16 per cent.

Investments

Three follow-on investments totalling £0.4 million were made in the period, demonstrating the portfolio's strong funding position.

Financial Results and Dividends

The movement in Total Return is set out in the table below:

 

 

Total Return

 

 

Pence per

ordinary share

Total Return at 1 January 2020

 

 

 

121.7

Net underlying change in portfolio

 

 

(4.3)

 

Net income after expenses

 

 

(0.5)

 

Movement in Total Return

 

 

 

(4.8)

Total Return at 30 June 2020

 

 

 

116.9

 

The fall in the value of the portfolio of 4.3 pence per ordinary share equates to £5.6 million (11.7 per cent of the opening value).

Investments made since the changes to the VCT rules in November 2015 now comprise £20.1 million (54 per cent, cost of £21.4 million) of the unquoted portfolio as at 30 June 2020, with £17.0 million (46 per cent, cost of £15.6 million) of investments made prior to the rule changes. In general, the more recent additions to the portfolio are re-investing their profits for growth, which means that the investments comprise mainly equity instruments.

The resultant movements in net asset value ("NAV") per ordinary share and the dividends paid are set out in the table below:

 

Net Asset Value

 

£000

Pence per

ordinary share

NAV at 1 January 2020

 

72,333

 

55.2

Gain on disposal of investments

1,567

 

 

 

Movement in investments held at fair value

(7,189)

 

 

 

Net underlying change in portfolio

(5,622)

 

(4.3)

 

Net income after expenses

(600)

 

(0.5)

 

Buy-back of shares

(868)

 

-

 

 

 

(7,090)

 

(4.8)

NAV before the payment of dividends

 

65,243

 

50.4

Dividends paid

 

(2,598)

 

(2.0)

NAV at 30 June 2020

 

62,645

 

48.4

 

Dividends

An interim dividend of 2.0 pence per ordinary share in respect of the year ended 31 December 2020 was paid on 12 May 2020, bringing the cumulative dividends paid to date to 68.5 pence per ordinary share.

Your Board has proposed an interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2020 which, when combined with the above dividend paid in the period will bring total dividends paid in the current financial year to 3.5 pence per ordinary share (2019: 8.0 pence per ordinary share). The interim dividend will be paid on 21 September 2020 to shareholders on the register on 20 August 2020.

Future performance is becoming more reliant on investments wholly financed with equity, rather than income-generating instruments and may also require additional funding rounds. As a result, future returns will be driven more by successful exits than income generation and in light of this your Board will continue to monitor the Company's dividend policy.

Shareholder Relations

As part of the Board's continuing communication with shareholders the Company had intended to hold its 25th shareholder workshop, in conjunction with British Smaller Companies VCT plc, in June this year. Due to the restrictions on holding large meetings that were in place at the time this had to be cancelled and has been rescheduled with a provisional date of 19 May 2021. We intend to hold the workshop at the original venue, One Great George Street, London.

Documents such as the annual report are now received by a large number of shareholders (83 per cent) via the website, www.bscfunds.com, rather than by post, which helps to meet the Board's impact objectives and reduces printing costs. Your Board continues to encourage all shareholders to take up this option.

Your Company's website www.bscfunds.com, is refreshed on a regular basis and provides a comprehensive level of information in what I hope is a user-friendly format.

Regulatory Developments

The majority of new investments are now self-assured on a case-by-case basis and always with confirmation from professional advisers that they are Qualifying Investments. Advance assurance is sought where there is an element of uncertainty over the application of the rules.

Board Composition

As noted in the Company's Interim Management Statement for the period ended 31 March 2020 Robert Pettigrew has indicated his intention to step down from the Board later this year. The Board has a strong shortlist of candidates for the position and whilst there are some logistical challenges it remains the intention to appoint a replacement later this year.

Outlook

Whilst a first wave of the Covid-19 outbreak appears to be behind us and restrictions on movement in the UK are being lifted uncertainty remains around the next few months in particular, recently evidenced by the removal and then relatively rapid replacement of restrictions on movements to and from Spain. Nonetheless there is broader consensus that in the medium-term the combined impacts of the aftershocks of the pandemic and the renegotiating of trading relationships with Europe are likely to dampen growth. However, while some sectors will take longer to recover than others, the current portfolio has the advantage of strong funding levels and low levels of leverage which puts it in the position to navigate through the short-term challenges and emerge strongly from this.

The Company has substantial resources with which it can undertake new investment opportunities. Albeit that the short- to medium-term economic outlook might be challenging, having liquidity to invest in those businesses operating in innovative ways in sectors where there is future growth, is itself a good opportunity. Whilst the conversion process of opportunity to new investment is currently a little slower than previously the Company is extremely well placed to take advantage of these opportunities as they arise.

 

Peter Waller

Chairman

 

OBJECTIVES AND STRATEGY

The Company's objective is over the long-term to maximise Total Return and provide investors with an attractive tax-free dividend yield while maintaining the Company's status as a venture capital trust.

The investment policy of the Company is to invest in UK businesses across a broad range of sectors that blends a mix of businesses operating in established and emerging industries that offer opportunities in the application and development of innovation in their products and services.

These investments will all meet the definition of a Qualifying Investment and be primarily in unquoted UK companies. It is anticipated that the majority of these will be high-growth businesses re-investing their profits for growth and the investments will, therefore, comprise mainly equity instruments.

The Company seeks to build a diversified portfolio in order to reduce concentration as well as ensuring compliance with the VCT guidelines in this regard.

 

INVESTMENTREVIEW

The Company's portfolio at 30 June 2020 had a value of £37.07 million. Investments made since the VCT rule changes in 2015 comprised £20.08 million (54 per cent of the total value of the portfolio). The largest single investment represents 11.9 per cent of the net asset value.

Realisation of Investments

The realisations of Business Collaborator and RMS produced combined capital proceeds of £5.64 million against aggregated costs of £1.41 million delivering a realised gain of £4.23 million of which £1.57 million was recognised in the period, representing an increase of 39 per cent over the carrying value at 31 December 2019.

Further details of these realisations can be found in note 6 to this interim report.

The impact across the economy of the Covid-19 pandemic has not been uniform, with sectors and performance impacted differently. To illustrate this we have analysed below the portfolio by sector and also shown the impact between the first and second quarters in the six-month period.

 

TABLE A

£000

31 Dec 2019

First Quarter

31 March 2020

Second Quarter

30 June 2020

TMT*

25,729

(3,159)

22,570

2,726

25,296

Travel

8,028

(2,101)

5,927

105

6,032

Business Services

4,005

(662)

3,343

402

3,745

Other

1,266

(7)

1,259

(40)

1,219

Retail & Hospitality

3,404

(2,136)

1,268

(653)

615

Manufacturing

833

(686)

147

11

158

Healthcare

299

(299)

-

-

-

 

43,564

(9,050)

34,514

2,551

37,065

In Realisation

4,349

(4,182)

167

(167)

-

Total

47,913

(13,232)

34,681

2,384

37,065

* Technology, media and telecommunications

By far the largest element (68 per cent at 30 June 2020) of the portfolio is invested in the TMT sector; this was heavily impacted in the 31 March 2020 valuations, but the trading resilience of the businesses and the sector has been reflected in the later part of the period with 86 per cent of the value recovered. Particularly notable movements in the period were gains in the value of Matillion £0.94 million and Arcus Global £0.48 million; and reductions in value of Biz2Mobile £0.65 million and SharpCloud £0.50 million.

The two sectors most directly impacted have been travel and retail & hospitality. Two investments comprise the Company's travel sector portfolio (ACC Aviation and Traveltek). The valuation reduction occurred all in the first quarter of the period; with valuations stabilised in the second quarter. Underlying trading has been stronger in both businesses than originally forecast at the end of March 2020 and both are well funded. The travel market has begun to open up in the current quarter, and although there may be an element of stop/start as has been seen with the quarantine restrictions around Spain, there are signs of a commencement of trading again in this sector.

The retail & hospitality sector has been the most directly impacted in the period. This is reflected in the valuations where the first quarter saw a reduction of £2.14 million and the second quarter a further £0.65 million. The residual value at 30 June 2020 is now only £0.62 million. There are three investments in this sector; Tonkotsu (a ramen restaurant chain); Friska (Bristol and Manchester food-to-go) and Frescobol Carioca (a beachwear retailer). All three have funding through to 2021 with each commencing trading again; Tonkotsu continuing home delivery and opening around 50 per cent of its outlets; Friska undertaking home delivery and Frescobol Carioca servicing its wholesale and on-line business, having now permanently closed its three stores. Whilst their valuations have been impacted in the short-term all three operate with minimal or no leverage and are beginning to build trade to deliver a contribution and have plans and funding that extend beyond the end of the Government's various initiatives.

Follow-on Investments

In the six months to 30 June 2020 the Company has invested £0.41 million into three follow-on investments into Friska, Ncam and Immunobiology.

 

INVESTMENT PORTFOLIO

The top 10 investments had a combined value of £27.9 million, 75.3 per cent of the total portfolio.

 

Name of Company

Sector

First

investment

Current

cost

 

£000

 

 

Value at

30 June 2020

 

£000

Proceeds

to date

 

£000

Capital return to date

£000

Matillion Limited

Software

Nov 16

1,778

7,431

-

7,431

ACC Aviation Group Limited

Business Services

Nov 14

145

5,052

1,233

6,285

Intelligent Office UK (IO Outsourcing t/a Intelligent Office)

Business Services

May 14

1,956

3,051

-

3,051

KeTech Enterprises Limited

Software

Nov 15

1,500

2,233

500

2,733

Unbiased EC1 Limited

Business Services

Dec 19

1,964

2,114

-

2,114

Springboard Research Holdings Limited

Business Services

Oct 14

1,883

1,892

-

1,892

Arcus Global Limited

Software

May 18

1,950

1,733

-

1,733

Deep-Secure Ltd

Software

Dec 09

500

1,479

-

1,479

Elucidat Ltd

Software

May 19

1,400

1,477

-

1,477

Wooshii Limited

Software

May 19

1,440

1,464

-

1,464

Total top 10 investments

 

 

14,516

27,926

1,733

29,659

Remaining portfolio

 

 

 

 

 

 

Ncam Technologies Limited

Software

Mar 18

1,500

1,203

-

1,203

Sipsynergy

(via Hosted Network Services Limited)

Software

Jun 16

1,309

1,001

-

1,001

Panintelligence (via Paninsight Limited)

Software

Nov 19

1,000

1,000

-

1,000

SharpCloud Software Limited

Software

Oct 19

1,460

956

-

956

DisplayPlan Holdings Limited

Business Services

Jan 12

70

694

820

1,514

Tonkotsu Limited

Retail & Brands

Jun 19

1,592

615

-

615

Traveltek Group Holdings Limited

Software

Oct 16

1,163

585

-

585

£0.5 million and below

 

 

14,385

3,085

5,600

8,685

Total portfolio

 

 

36,995

37,065

8,153

45,218

Full disposals to date

 

 

34,769

-

51,419

51,419

Total portfolio 

 

 

71,764

37,065

59,572

96,637

         

 

OUR PORTFOLIO AT A GLANCE

The charts on pages 12 and 13 of the interim report illustrate the broad range of the investment portfolio.

 

PRINCIPAL RISKS AND UNCERTAINTIES

In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Accounts for the year ended 31 December 2019. The Board acknowledges that there is regulatory risk and continues to manage the Company's affairs in such a manner as to comply with section 274 of the Income Tax Act 2007.

In summary, the principal risks are:

• Loss of approval as a Venture Capital Trust;

• Economic;

• Investment and strategic;

• Regulatory;

• Reputational;

• Operational;

• Financial; and

• Market/liquidity.

Full details of the principal risks can be found in the financial statements for the year ended 31 December 2019 on pages 33 to 35, a copy of which is available at www.bscfunds.com.

 

DIRECTORS' RESPONSIBILITIES STATEMENT

The directors of British Smaller Companies VCT2 plc confirm that, to the best of their knowledge, the condensed set of financial statements in this interim report have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" as adopted by the EU, and give a true and fair view of the assets, liabilities, financial position and profit and loss of British Smaller Companies VCT2 plc, and that the interim management report includes a true and fair review of the information required by DTR 4.2.7R and DTR 4.2.8R.

The directors of British Smaller Companies VCT2 plc are listed in note 9 of these interim financial statements.

 

By order of the Board

 

Peter Waller

Chairman

 

UNAUDITED STATEMENT OF COMPREHENSIVE INCOME

for the six months ended 30 June 2020

 

 

 

Unaudited 6 months ended

30 June 2020

Unaudited 6 months ended

30 June 2019

 

Notes

Revenue

Capital

Total

Revenue

Capital

Total

 

 

£000

£000

£000

£000

£000

£000

Gains on disposal of investments

6

-

1,567

1,567

-

130

130

(Losses) gains on investments held at fair value

6

-

(7,189)

(7,189)

-

255

255

 

 

-

(5,622)

(5,622)

-

385

385

Income

2

450

-

450

552

-

552

Total income

 

450

(5,622)

(5,172)

552

385

937

Administrative expenses:

 

 

 

 

 

 

 

Manager's fee

 

(163)

(491)

(654)

(141)

(424)

(565)

Other expenses

 

(228)

-

(228)

(231)

-

(231)

Fair value movement related to credit risk

 

(168)

-

(168)

-

-

-

 

 

(559)

(491)

(1,050)

(372)

(424)

(796)

(Loss) profit before taxation

(109)

(6,113)

(6,222)

180

(39)

141

Taxation

3

-

-

-

(5)

5

-

(Loss) profit for the period

 

(109)

(6,113)

(6,222)

175

(34)

141

Total comprehensive (expense) income for the period

 

(109)

(6,113)

(6,222)

175

(34)

141

Basic and diluted (loss) earnings per ordinary share

5

(0.08p)

(4.69p)

(4.77p)

0.15p

(0.03p)

0.12p

 

The Total column of this statement represents the Company's Unaudited Statement of Comprehensive Income, prepared in accordance with International Financial Reporting Standards as adopted by the European Union ('IFRSs'). The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (issued in October 2019 - "SORP") published by the Association of Investment Companies.

 

UNAUDITED BALANCE SHEET

as at 30 June 2020

 

 

Notes

Unaudited

30 June

2020

 

Unaudited

30 June

2019

 

Audited

31 December

2019

 

 

 

£000

£000

£000

Assets

 

 

 

 

Non-current assets at fair value through profit and loss

 

 

 

 

Financial assets

6

37,065

43,725

47,913

Accrued income and other assets

 

326

504

488

 

 

37,391

44,229

48,401

Current assets

 

 

 

 

Accrued income and other assets

 

155

505

166

Cash on fixed term deposit

 

1,988

1,988

1,988

Cash and cash equivalents

 

23,209

23,534

21,944

 

 

25,352

26,027

24,098

Liabilities

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

(98)

(80)

(166)

Net current assets

 

25,254

25,947

23,932

Net assets

 

62,645

70,176

72,333

 

 

 

 

 

Shareholders' equity

 

 

 

 

Share capital

 

14,041

13,949

14,041

Share premium account

 

16,436

16,105

16,436

Capital redemption reserve

 

88

88

88

Other reserve

 

2

2

2

Merger reserve

 

5,525

5,525

5,525

Capital reserve

 

25,681

25,586

25,223

Investment holding gains and losses reserve

 

100

7,868

9,948

Revenue reserve

 

772

1,053

1,070

Total shareholders' equity

 

62,645

70,176

72,333

Net asset value per ordinary share

7

48.4p

53.4p

55.2p

 

 

Signed on behalf of the Board

 

Peter Waller

Chairman

 

UNAUDITED STATEMENT OF CHANGES IN EQUITY

for the six months ended 30 June 2020

 

 

Share

capital

Share

premium

account

Other

reserves*

Capital

reserve

Investment

holding

gains and

losses reserve

Revenue

reserve

Total

equity

 

£000

£000

£000

£000

£000

£000

£000

At 31 December 2018

11,318

4,351

5,615

33,694

7,335

1,741

64,054

Revenue return for the period

-

-

-

-

-

180

180

Capital expenses

-

-

-

(424)

-

-

(424)

Investment holding gain on investments held at fair value

-

-

-

-

255

-

255

Realisation of investments in the period

-

-

-

130

-

-

130

Taxation

-

-

-

5

-

(5)

-

Total comprehensive (expense) income for the period

-

-

-

(289)

255

175

141

Issue of ordinary share capital

2,321

10,959

-

-

-

-

13,280

Issue of shares - DRIS

310

1,259

-

-

-

-

1,569

Issue costs of ordinary shares**

-

(464)

-

(136)

-

-

(600)

Purchase of own shares

-

-

-

(942)

-

-

(942)

Dividends

-

-

-

(6,463)

-

(863)

(7,326)

Total transactions with owners

2,631

11,754

-

(7,541)

-

(863)

5,981

Realisation of prior year investment holding losses

-

-

-

(278)

278

-

-

At 30 June 2019

13,949

16,105

5,615

25,586

7,868

1,053

70,176

Revenue return for the period

-

-

-

-

-

57

57

Capital expenses

-

-

-

(468)

-

-

(468)

Investment holding loss on investments held at fair value

-

-

-

-

2,068

-

2,068

Realisation of investments in the period

-

-

-

2,738

-

-

2,738

Taxation

-

-

-

(5)

-

5

-

Total comprehensive income for the period

-

-

-

2,265

2,068

62

4,395

Issue of shares - DRIS

92

362

-

-

-

-

454

Issue costs of ordinary shares**

-

(31)

-

-

-

-

(31)

Purchase of own shares

-

-

-

(688)

-

-

(688)

Dividends

-

-

-

(1,928)

-

(45)

(1,973)

Total transactions with owners

92

331

-

(2,616)

-

(45)

(2,238)

Realisation of prior year investment holding losses

-

-

-

(12)

12

-

-

At 31 December 2019

14,041

16,436

5,615

25,223

9,948

1,070

72,333

 

Revenue return for the period

-

-

-

-

-

(109)

(109)

Capital expenses

-

-

-

(491)

-

-

(491)

Investment holding loss on investments held at fair value

-

-

-

-

(7,189)

-

(7,189)

Realisation of investments in the period

-

-

-

1,567

-

-

1,567

Total comprehensive income (expense) for the period

-

-

-

1,076

(7,189)

(109)

(6,222)

Purchase of own shares

-

-

-

(868)

-

-

(868)

Dividends

-

-

-

(2,409)

-

(189)

(2,598)

Total transactions with owners

-

-

-

(3,277)

-

(189)

(3,466)

Realisation of prior year investment holding gains

-

-

-

2,659

(2,659)

-

-

At 30 June 2020

14,041

16,436

5,615

25,681

100

772

62,645

*Other reserves include the capital redemption reserve, the merger reserve and the other reserve, which are non-distributable.

**Issue costs include both fundraising costs (where applicable) and costs incurred from the Company's DRIS.

 

Reserves available for distribution

Under the Companies Act 2006 the capital reserve and the revenue reserve are distributable reserves. The table below shows amounts that are available for distribution.

 

Capital reserve

£000

Revenue reserve

£000

Total

£000

 

Distributable reserves as above

25,681

772

26,453

Less : Income not yet distributable

-

(752)

(752)

: Cancelled share premium not yet distributable

(3,677)

-

(3,677)

Reserves available for distribution*

22,004

20

22,024

* subject to filing these interim financial statements at Companies House.

The capital reserve and the revenue reserve are both distributable reserves. These reserves total £26,453,000, representing an increase of £160,000 in the period since 31 December 2019. The directors also take into account the level of the investment holding gains and losses reserve and the future requirements of the Company when determining the level of dividend payments.

Of the potentially distributable reserves of £26,453,000 shown above, £752,000 relates to income not yet receivable and £3,677,000 to cancelled share premium which becomes distributable from 1 January 2021.

 

UNAUDITED STATEMENT OF CASH FLOWS

for the six months ended 30 June 2020

 

Notes

Unaudited

6 months

ended

30 June

2020

Unaudited

6 months

ended

30 June

2019

Audited

year

ended

31 December

2019

 

 

£000

£000

£000

(Loss) profit before taxation

 

(6,222)

141

4,536

Decrease in trade and other payables

 

(68)

(90)

(4)

Decrease (increase) in accrued income and other assets

 

173

(96)

136

Gains on disposal of investments

 

(1,567)

(130)

(2,868)

Losses (gains) on investments held at fair value

 

7,189

(255)

(2,323)

Capitalised income

 

-

-

(59)

Net cash outflow from operating activities

 

(495)

(430)

(582)

Cash flows from investing activities

 

 

 

 

Purchase of financial assets at fair value through profit or loss

6

(410)

(6,867)

(11,413)

Proceeds from sale of financial assets at fair value through profit or loss

6

5,636

1,612

6,835

Deferred consideration

 

-

123

246

Net cash inflow (outflow) from investing activities

 

5,226

(5,132)

(4,332)

Cash flows from financing activities

 

 

 

 

Issue of ordinary shares

 

-

13,280

13,280

Costs of ordinary share issues*

 

-

(600)

(631)

Purchase of own shares

 

(868)

(942)

(1,631)

Dividends paid

4

(2,598)

(5,757)

(7,275)

Net cash (outflow) inflow from financing activities

 

(3,466)

5,981

3,743

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

1,265

419

(1,171)

Cash and cash equivalents at the beginning of the period

 

21,944

23,115

23,115

Cash and cash equivalents at the end of the period

 

23,209

23,534

21,944

 

*Issue costs include both fundraising costs and expenses incurred from the Company's DRIS.

 

EXPLANATORY NOTES TO THE UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

1 General Information, Basis of Preparation and Principal Accounting Policies

These half year statements have been approved by the directors whose names appear at note 9, each of whom has confirmed that to the best of his knowledge:

• the interim management report includes a fair review of the information required by rules 4.2.7 and 4.2.8 of the Disclosure Rules and the Transparency Rules; and

• the half year statements have been prepared in accordance with IAS 34 'Interim financial reporting' and the Disclosure and Transparency Rules of the Financial Conduct Authority.

The half year statements are unaudited and have not been reviewed by the auditors pursuant to the Auditing Practices Board (APB) guidance on Review of Interim Financial Information. They do not constitute full financial statements as defined in section 435 of the Companies Act 2006. The comparative figures for the year ended 31 December 2019 do not constitute full financial statements and have been extracted from the Company's financial statements for the year ended 31 December 2019. Those accounts were reported upon without qualification by the auditors and have been delivered to the Registrar of Companies.

The accounting policies and methods of computation followed in the half year statements are the same as those adopted in the preparation of the audited financial statements for the year ended 31 December 2019.

The financial statements for the year ended 31 December 2019 were prepared in accordance with the International Financial Reporting Standards (IFRSs) as adopted by the European Union and those parts of the Companies Act 2006 applicable to companies reporting under IFRS. Where guidance set out in the SORP is consistent with the requirements of IFRS, the financial statements have been prepared in compliance with the recommendations of the SORP.

Standards, amendments to standards and interpretations have been issued which are effective for the current reporting period. The Company has carried out an assessment and considers that these standards, amendments and interpretations do not affect the Company's accounting policies, results or net assets.

The financial statements are presented in sterling and all values are rounded to the nearest thousand (£000), except where stated.

Going Concern: The directors have carefully considered the issue of going concern and are satisfied that the Company has sufficient resources to meet its obligations as they fall due for a period of at least twelve months from the date these half year statements were approved. As at 30 June 2020 the Company held cash balances and fixed term deposits with a combined value of £25,197,000. Cash flow projections show the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of share buy-backs and the dividend policy. In the year ended 31 December 2019 the Company's costs and discretionary expenditures were:

 

£'000

Administrative expenses (before fair value movements related to credit risk)

1,666

Share buybacks

1,631

Dividends (before DRIS)

9,299

Total

12,596

 

The directors therefore believe that it is appropriate to continue to apply the going concern basis of accounting in preparing these half year statements.

 

2 Income

 

Unaudited

6 months

ended

30 June

2020

£000

Unaudited

6 months

ended

30 June

2019

£000

Income from investments

 

 

- Dividends from unquoted companies

177

149

- Dividends from AIM quoted companies

-

2

 

177

151

- Interest on loans to unquoted companies

187

289

Income from investments held at fair value through profit or loss

364

440

Interest on bank deposits

86

112

 

450

552

 

3 Taxation

 

Unaudited 6 months ended

30 June 2020

Unaudited 6 months ended

30 June 2019

 

Revenue

Capital

Total

Revenue

Capital

Total

 

£000

£000

£000

£000

£000

£000

(Loss) profit before taxation

(109)

(6,113)

(6,222)

180

(39)

141

(Loss) profit before taxation multiplied by the standard small company rate of corporation tax in UK of 19.0% (2019: 19.0%)

(21)

(1,161)

(1,182)

34

(7)

27

Effect of:

 

 

 

 

 

 

UK dividends received

(21)

-

(21)

(29)

-

(29)

Non-taxable profits on investments

-

1,068

1,068

-

(73)

(73)

Deferred tax not recognised

42

93

135

-

75

75

Tax charge (credit)

-

-

-

5

(5)

-

 

The Company has no provided, or unprovided, deferred tax liability in either period.

Deferred tax assets in respect of losses have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which the assets can be recovered.

Due to the Company's status as a venture capital trust, and the continued intention to meet the conditions required to comply with Chapter 3 Part 6 of the Income Tax Act 2007, the Company has not provided deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.

 

4 Dividends

Amounts recognised as distributions to equity holders in the period:

 

 

Unaudited

6 months ended

30 June 2020

Unaudited

6 months ended

30 June 2019

Audited

Year ended

31 December 2019

 

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

£000

£000

£000

£000

£000

£000

£000

£000

£000

Interim dividend for the year ending 31 December 2020 of 2.0p (2019: 1.5p) per ordinary share

189

2,409

2,598

-

-

-

45

1,928

1,973

 

 

 

 

 

 

 

 

 

 

Final dividend for the year ended 31 December 2018 of 1.5p per ordinary share

-

-

-

785

1,190

1,975

785

1,190

1,975

 

 

 

 

 

 

 

 

 

 

Special interim dividend for the year ended 31 December 2019 of 2.0p per ordinary share

-

-

-

78

5,273

5,351

78

5,273

5,351

 

189

2,409

2,598

863

6,463

7,326

908

8,391

9,299

Shares allotted under DRIS

 

 

-

 

 

(1,569)

 

 

(2,024)

Dividends paid in the Statement of Cash Flows

 

 

2,598

 

 

5,757

 

 

7,275

 

The interim dividend of 2.0 pence per ordinary share was paid on 12 May 2020 to shareholders on the register as at 14 April 2020.

 

An interim dividend of 1.5 pence per ordinary share, amounting to approximately £1.9 million, is proposed. The dividend has not been recognised in these half year financial statements as the obligation did not exist at the balance sheet date.

 

5 Basic and Diluted (Loss) Earnings per Ordinary Share

The basic and diluted (loss) earnings per ordinary share is based on the loss after tax attributable to equity shareholders of £6,222,000 (30 June 2019: profit of £141,000) and 130,407,271 (30 June 2019: 120,024,534) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted revenue (loss) earnings per ordinary share is based on the revenue loss attributable to equity shareholders of £109,000 (30 June 2019: profit of £175,000) and 130,407,271 (30 June 2019: 120,024,534) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted capital loss per ordinary share is based on the capital loss attributable to equity shareholders of £6,113,000 (30 June 2019: £34,000) and 130,407,271 (30 June 2019: 120,024,534) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The Company has repurchased 1,726,762 of its own shares in the period and these shares are held in the capital reserve. The total of 11,035,854 treasury shares has been excluded in calculating the weighted average number of ordinary shares during the period.

The Company has no dilutive shares and consequently, basic and diluted earnings per ordinary share are equivalent at 30 June 2020, 31 December 2019 and 30 June 2019.

 

6 Financial Assets at Fair Value through Profit or Loss

IFRS 13 and IFRS 7, in respect of financial instruments that are measured in the balance sheet at fair value, require disclosure of fair value measurements by level within the following fair value measurement hierarchy:

Level 1: quoted prices in active markets for identical assets or liabilities. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is defined as a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The quoted market price used for financial assets held by the Company is the current bid price. The Company does not currently hold any Level 1 investments.Level 2: the fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2. The Company held no such instruments in the current or prior year.Level 3: the fair value of financial instruments that are not traded in an active market (for example, investments in unquoted companies) is determined by using valuation techniques such as earnings or sales multiples. If one or more of the significant inputs is not based on observable market data, the instrument is included in Level 3. All of the Company's investments fall into this category.

Each investment is reviewed at least quarterly to ensure that it has not ceased to meet the criteria of the level in which it was included at the beginning of each accounting period. There have been no transfers between these classifications in the period (2019: none).

The change in fair value for the current and previous year is recognised through profit or loss. All items held at fair value through profit or loss were designated as such upon initial recognition.

Valuation of Investments

Unquoted investments are valued in accordance with IFRS 13 "Fair Value Measurement" and, using the International Private Equity and Venture Capital ("IPEVC") Valuation Guidelines ("the Guidelines") issued in December 2018 and updated in March 2020.

Initial measurement

The best estimate of the initial fair value of an unquoted investment is the cost of the investment. Unless there are indications that this is inappropriate, an unquoted investment will be held at this value within the first three months of investment.

Subsequent measurement

Based on the Guidelines we have identified six of the most widely used valuation methodologies for unquoted investments. The Guidelines advocate that the best valuation methodologies are those that draw on external, objective market-based data in order to derive a fair value.

Full details of the methods used by the Company were set out on pages 66 and 67 of the financial statements for the year ended 31 December 2019, a copy of which can be found at www.bscfunds.com.

The primary methods used for valuing non-quoted investments, and the key assumptions relating to them are:

Unquoted Investments

· sales multiples. An appropriate multiple, given the risk profile and sales growth prospects of the underlying company, is applied to the revenue of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

· earnings multiple. An appropriate multiple, given the risk profile and earnings growth prospects of the underlying company, is applied to the maintainable earnings of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

Movements in investments at fair value through profit or loss during the six months to 30 June 2020 are summarised as follows:

IFRS 13 measurement classification

 

 

Level 3

Unquoted

Investments

 

 

£000

Opening cost

 

 

37,995

Opening valuation gain

 

 

9,918

Opening fair value at 1 January 2020

 

 

47,913

Additions at cost

 

 

410

Disposal proceeds

 

 

(5,636)

Net profit on disposal

 

 

1,567

Change in fair value

 

 

(7,189)

Closing fair value at 30 June 2020

 

 

37,065

Closing cost

 

 

36,995

Closing valuation gain

 

 

70

Closing fair value at 30 June 2020

 

 

37,065

Level 3 valuations include assumptions based on non-observable data, such as discounts applied either to reflect changes in fair value of financial assets held at the price of recent investment, or to adjust earnings multiples.

IFRS13 requires disclosure, by class of financial instruments, if the effect of changing one or more inputs to reasonably possible alternative assumptions would result in a significant change to fair value measurement. Each unquoted portfolio company has been reviewed and both downside and upside alternative assumptions have been identified and applied to the valuation of each of the unquoted investments. Applying the downside alternative the value of the unquoted investments would be £2,173,000 (5.9 per cent) lower. Using the upside alternative the value would be increased by £2,016,000 (5.4 per cent).

All the Company's investments are in unquoted companies held at fair value. The valuation methodology for these investments includes the application of externally produced sales multiples and FTSE® PE multiples. Therefore the value of the unquoted element of the portfolio is also indirectly affected by price movements on the listed market. Those using earnings and sales multiple methodologies include judgements regarding the level of discount applied to that multiple. A 10 per cent decrease in the discount applied would have increased the net assets attributable to the Company's shareholders and the total profit by £3,121,000 (5.0 per cent of net assets). An equal change in the opposite direction would have decreased net assets attributable to the Company's shareholders and the total profit by £2,931,000 (4.7 per cent of net assets).

There have been no individual fair value adjustments downwards during the period that exceeded 5 per cent of the total assets of the Company (31 December 2019: none).

The following disposals and loan repayments took place during the period.

 

 

Net

proceeds

from sale

 

Cost

 

Opening

carrying

value as at

1 January

2020

Gain (loss)

over

opening

carrying

value

 

£000

£000

£000

£000

Unquoted investments

 

 

 

 

Business Collaborator Limited

5,074

1,340

3,458

1,616

RMS Holdings Limited

562

70

611

(49)

Total from disposals in the period

5,636

1,410

4,069

1,567

 

7 Basic and Diluted Net Asset Value per Ordinary Share

The basic and diluted net asset value per ordinary share is calculated on attributable assets of £62,645,000 (30 June 2019 and 31 December 2019: £70,176,000 and £72,333,000 respectively) and 129,373,784 (30 June 2019 and 31 December 2019: 131,512,395 and 131,100,546 respectively) ordinary shares in issue at 30 June 2020.

The 11,035,854 (30 June 2019 and 31 December 2019: 7,974,092 and 9,309,092 respectively) treasury shares have been excluded in calculating the number of ordinary shares in issue at 30 June 2020.

The Company has no potentially dilutive shares and consequently, basic and diluted net asset values are equivalent at 30 June 2020, 31 December 2019 and 30 June 2019.

 

8 Total Return

Total Return per ordinary share is calculated on cumulative dividends paid of 68.5 pence per ordinary share (30 June 2019: 65.0 pence per ordinary share and 31 December 2019: 66.5 pence per ordinary share) plus the net asset value as calculated in note 7.

9 Directors

 

The directors of the Company are: Peter Charles Waller, Robert Martin Pettigrew, and Roger Steven McDowell.

 

10 Other Information

Copies of the interim report can be obtained from the Company's registered office: 5th Floor, Valiant Building, 14 South Parade, Leeds, LS1 5QS or from www.bscfunds.com.

 

11 Interim Dividend for the year ending 31 December 2020

The directors are pleased to announce the payment of an interim dividend for the year ending 31 March 2021 of 1.5 pence per ordinary share ("Interim Dividend").

The Interim Dividend will be paid on 21 September 2020 to those shareholders on the Company's register at the close of business on 20 August 2020. The ex-dividend date will be 19 August 2020.

 

12 Dividend Re-investment Scheme

The Company operates a dividend re-investment scheme ("DRIS"). The latest date for receipt of DRIS elections so as to participate in the DRIS in respect of the Interim Dividend is the close of business on 7 September 2020.

 

13 Inside Information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR UAOBRRVUWAAR
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.